{"id":"https://openalex.org/W4388042610","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0328","title":"328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies","display_name":"328 Preclinical analyses and proof of concept clinical study of Epstein Barr Virus (EBV) specific genetically modified T cells against EBV associated malignancies","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388042610","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0328"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0328","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0328","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0328","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/374.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/374.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101786899","display_name":"Xinfeng Chen","orcid":"https://orcid.org/0000-0001-6992-1957","observed_orcids":["https://orcid.org/0000-0001-6992-1957"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin-Feng Chen","raw_affiliation_strings":["Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]},{"raw_affiliation_string":"The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100411839","display_name":"Dan Wang","orcid":"https://orcid.org/0000-0002-6403-3835","observed_orcids":["https://orcid.org/0000-0002-6403-3835"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Dan Wang","raw_affiliation_strings":["Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]},{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113033697","display_name":"Jianmin Huan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jianmin Huan","raw_affiliation_strings":["Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092083396","display_name":"Xudong Zhang","orcid":"https://orcid.org/0000-0001-8515-8189","observed_orcids":["https://orcid.org/0000-0001-8515-8189","https://orcid.org/0000-0002-1930-5563"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xudong Zhang","raw_affiliation_strings":["Biosyngen Pte Ltd","Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosyngen Pte Ltd","institution_ids":[]},{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102019275","display_name":"Ling Li","orcid":"https://orcid.org/0000-0001-5565-9409","observed_orcids":["https://orcid.org/0000-0001-5565-9409"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ling Li","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100430853","display_name":"Xi Zhang","orcid":"https://orcid.org/0000-0002-8548-2832","observed_orcids":["https://orcid.org/0000-0002-8548-2832"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"XI Zhang","raw_affiliation_strings":["Biosyngen Pte Ltd","Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosyngen Pte Ltd","institution_ids":[]},{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007570262","display_name":"Renata Stripecke","orcid":"https://orcid.org/0000-0001-7756-8460","observed_orcids":["https://orcid.org/0000-0001-7756-8460"]},"institutions":[{"id":"https://openalex.org/I180923762","display_name":"University of Cologne","ror":"https://ror.org/00rcxh774","country_code":"DE","type":"education","lineage":["https://openalex.org/I180923762"]},{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Renata Stripecke","raw_affiliation_strings":["Hannover Medical School, Hannover, Germany","Institute for Translational Immune-Oncology, Cancer Research Center Cologne-Essen (CCCE), University of Cologne, Cologne, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hannover Medical School, Hannover, Germany","institution_ids":["https://openalex.org/I34809795"]},{"raw_affiliation_string":"Institute for Translational Immune-Oncology, Cancer Research Center Cologne-Essen (CCCE), University of Cologne, Cologne, Germany","institution_ids":["https://openalex.org/I180923762"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064870453","display_name":"Scott R. Burrows","orcid":"https://orcid.org/0000-0002-1430-0472","observed_orcids":["https://orcid.org/0000-0002-1430-0472"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Scott Burrows","raw_affiliation_strings":["Queensland Institute of Medical Research, Herston, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queensland Institute of Medical Research, Herston, QLD, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100909097","display_name":"Deping Han","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deping Han","raw_affiliation_strings":["Biosyngen Pte Ltd, Singapore, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biosyngen Pte Ltd, Singapore, Singapore","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904767","display_name":"Mingzhi Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mingzhi Zhang","raw_affiliation_strings":["Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100388089","display_name":"Yi Zhang","orcid":"https://orcid.org/0000-0001-9861-4681","observed_orcids":["https://orcid.org/0000-0001-9861-4681"]},"institutions":[{"id":"https://openalex.org/I4210156804","display_name":"First Affiliated Hospital of Zhengzhou University","ror":"https://ror.org/056swr059","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156804"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yi Zhang","raw_affiliation_strings":["Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]},{"raw_affiliation_string":"Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China","institution_ids":["https://openalex.org/I4210156804"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A374","last_page":"A375"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ebv-specific-t-cells","display_name":"EBV-specific T cells","score":0.7210000157356262},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.7829999923706055},{"id":"https://openalex.org/keywords/tcr-engineered-t-cells","display_name":"TCR-engineered T cells","score":0.8379999995231628},{"id":"https://openalex.org/keywords/lentiviral-transduction","display_name":"lentiviral transduction","score":0.878000020980835},{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.9710000157356262},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.6650000214576721},{"id":"https://openalex.org/keywords/ebv-associated-malignancies","display_name":"EBV-associated malignancies","score":0.8349999785423279},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.5649999976158142},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.5120000243186951},{"id":"https://openalex.org/keywords/viral-load-reduction","display_name":"viral load reduction","score":0.42100000381469727},{"id":"https://openalex.org/keywords/lymphoproliferative-disorders","display_name":"lymphoproliferative disorders","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5453252196311951},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5269780158996582},{"id":"https://openalex.org/C2776995267","wikidata":"https://www.wikidata.org/wiki/Q4165484","display_name":"Lymphoproliferative disorders","level":3,"score":0.5185416340827942},{"id":"https://openalex.org/C2781375147","wikidata":"https://www.wikidata.org/wiki/Q6900","display_name":"Epstein\u2013Barr virus","level":3,"score":0.5131507515907288},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4976561367511749},{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.4734603762626648},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4411129057407379},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4345664978027344},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43040359020233154},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4121054410934448},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3929483890533447},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3835698366165161},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.23358476161956787},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.21589705348014832},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0328","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0328","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0328","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/374.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:f653454d35074ba297d71dcadb9e3dad","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f653454d35074ba297d71dcadb9e3dad","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0328","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0328","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1136/jitc-2023-sitc2023.0328","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/374.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388042610.pdf","grobid_xml":"https://content.openalex.org/works/W4388042610.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4318998214","https://openalex.org/W2784420848","https://openalex.org/W2312582054","https://openalex.org/W3033731963","https://openalex.org/W4405049491","https://openalex.org/W2214670055","https://openalex.org/W1925842749","https://openalex.org/W3047637160","https://openalex.org/W4375855544","https://openalex.org/W2023634182"],"abstract_inverted_index":{"Background":[0],"Epstein":[1],"Barr":[2,442],"virus":[3],"(EBV)":[4],"is":[5,14],"a":[6],"highly":[7],"prevalent":[8],"herpesvirus":[9],"worldwide":[10],"and":[11,27,58,129,136,155,184,191,213,313,364,414,537,544,575,598,631,638],"its":[12],"infection":[13],"associated":[15],"with":[16,48,89,115,199,239,310,316,320,361,528,533,625,627,660],"malignancies":[17,102],"such":[18,52,158,386],"as":[19,53,159,243,387,418,690],"nasopharyngeal":[20,510],"cancer":[21,26,511],"(NPC),":[22],"gastric":[23],"cancer,":[24],"lymphoepithelioma":[25],"lymphoproliferative":[28,311],"disorders.":[29],"Virus-specific":[30],"T":[31,36,64,84,106,138,169,195,279,289,323,381,482,679],"(VST)":[32],"cell":[33,139,261,280,483,530,663,680],"therapies":[34],"using":[35,378,698],"cells":[37,65,85,107,170,196,224,290,324,355,382,560,580,654],"reactive":[38],"against":[39,99,234,448],"EBV":[40,87,100,119,125,200,235,335,384,456,486,562],"have":[41,79,230],"shown":[42],"limited":[43],"efficacy":[44,149,166],"in":[45,66,173,182,225,297,330,655],"clinical":[46,94,306,424,490],"trials":[47],"several":[49],"practical":[50],"limitations":[51],"the":[54,59,75,81,137,164,210,232,264,273,277,305,331,334,375,429,455,476,569,590,606,687,702],"long":[55],"preparation":[56],"period":[57],"variations":[60],"of":[61,74,167,209,257,263,286,377,433,454,475,522,552,572,608,619,646,652,686],"pre-existing":[62],"EBV-reactive":[63],"different":[67],"donors.":[68],"To":[69],"overcome":[70],"these":[71],"technical":[72],"constraints":[73],"VST":[76],"approach,":[77],"we":[78],"established":[80],"genetically":[82,379],"engineered":[83,265,287,321,380],"targeting":[86,383],"antigens":[88,385],"lentiviral":[90],"transduction.":[91],"A":[92],"proof-of-concept":[93],"validation":[95],"was":[96,150,171,426,539,566,592,603,633,673],"further":[97,130],"conducted":[98,409],"+":[101],"(trial":[103],"No.":[104],"ChiCTR2100044497).Methods":[105],"were":[108,141,186,408,526,581,623],"activated":[109],"by":[110,143,152,188,245,420,428,493,692,696],"CD3/CD28":[111],"stimulation,":[112],"lentivirally":[113,197],"transduced":[114,198],"codon-optimized":[116],"CAR":[117,202,458,477],"(targeting":[118,124],"envelope":[120,388,497,563],"protein)":[121,128],"or":[122,203,268,390,446,459,478],"TCR":[123,204,460,479],"latent":[126,236,391,505,666],"membrane":[127,237,392,506,667],"expanded":[131],"ex":[132],"vivo.":[133],"Transgene":[134],"expression":[135,208,480,488,499,508],"phenotype":[140],"assessed":[142],"flow":[144],"cytometry.":[145],"In":[146,162,250,304,518,615,649],"vitro":[147,226,251,519,616],"anti-tumor":[148,295],"analyzed":[151],"IFN-\u03b3":[153],"ELISA":[154,543,637],"killing":[156,256],"assays":[157,253],"RTCA":[160],"Xcelligence.":[161],"vivo,":[163],"antitumor":[165],"EBV-specific":[168,266,288,523,620],"evaluated":[172,187],"immunocompromised":[174,298],"mice":[175,574,610,658],"bearing":[176],"human":[177],"tumor":[178,223,260,491],"xenografts.":[179],"Anti-tumor":[180],"responses":[181,296],"lymphoma":[183,502],"NPC":[185,318,332],"Lugano":[189],"2014":[190],"RECIST":[192],"1.1":[193],"respectively.Results":[194],"antigen-specific":[201],"demonstrated":[205,254,357],"satisfactory":[206,358],"surface":[207],"introduced":[211],"receptor":[212],"showed":[214],"increased":[215],"cytokine":[216,368],"production":[217],"when":[218],"stimulated":[219],"to":[220,293,345,394,541,635,701],"target":[221],"expressing":[222,561,665],"(figure":[227,302],"1).":[228,303],"We":[229],"identified":[231],"TCRs":[233],"protein":[238,389,393,507,564,668],"high":[240],"functional":[241,248,520,617],"avidity":[242],"determined":[244,691],"peptide":[246],"dose-response":[247],"assays.":[249],"cytotoxicity":[252,546,640],"strong":[255],"antigen":[258,487],"positive":[259],"lines":[262],"CAR-T":[267,445,525,591],"TCR-T":[269,447,622,653],"cells,":[270,275],"while":[271],"sparing":[272],"antigen-negative":[274],"indicating":[276],"specific":[278,457,700],"response.":[281],"The":[282,353,423,587,601,683],"single":[283],"intravenous":[284],"infusion":[285],"also":[291,356],"led":[292],"dose-dependent":[294],"mouse":[299],"xenograft":[300],"models":[301],"trial,":[307],"two":[308],"patients":[309,689],"disease":[312],"one":[314],"patient":[315],"advanced":[317],"treated":[319],"EBV-targeting":[322],"experienced":[325],"sustained":[326],"objective":[327],"responses.":[328],"Moreover,":[329],"patient,":[333],"DNA":[336],"copy":[337],"number":[338],"decreased":[339],"from":[340,611],"3.32*103":[341],"copies/ml":[342,693],"at":[343,410],"baseline":[344],"normal":[346],"(<5.00*102":[347],"copies/ml)":[348],"2":[349,367],"months":[350],"post":[351,678],"infusion.":[352],"infused":[354],"safety":[359],"profile":[360],"no":[362],"neurotoxicity":[363],"\u2265":[365],"Grade":[366],"release":[369],"syndrome":[370],"observed.Conclusions":[371],"Our":[372],"data":[373],"demonstrate":[374],"feasibility":[376],"treat":[395],"EBV-associated":[396,449],"malignancies.Trial":[397],"Registration":[398],"Chinese":[399],"Clinical":[400],"Trial":[401],"Registry:":[402],"ChiCTR2100044497Ethics":[403],"Approval":[404],"All":[405],"animal":[406],"studies":[407],"Guangzhou":[411],"Regenerative":[412],"Medicine":[413],"Health,":[415],"Guangdong":[416],"Laboratory":[417],"approved":[419,427],"IACUC":[421],"(2020125).":[422],"study":[425],"first":[430],"affiliated":[431],"hospital":[432],"Zhengzhou":[434],"University\u2019s":[435],"Ethics":[436],"Board":[437],"(L2021-Y027\u2013005).Abstract":[438],"328":[439],"Figure":[440],"1Epstein":[441],"Virus":[443],"(EBV)-specific":[444],"malignancies.":[450],"(A)":[451],"Schematic":[452],"overview":[453],"construct.":[461,704],"SR":[462],"signal":[463],"peptide.":[464],"TM,":[465],"transmembrane":[466],"domain.":[467,470],"ICD,":[468],"intracellular":[469],"(B)":[471],"Flow":[472],"cytometric":[473],"analysis":[474],"on":[481,489,500,509,584],"surface.":[484],"(C)":[485],"samples":[492],"immunohistochemistry":[494],"analysis.":[495],"Top,":[496],"glycoprotein":[498],"EBV+":[501],"tissues;":[503],"Bottom:":[504],"tissues.":[512],"Scale":[513],"bar,":[514],"50":[515],"\u00b5m.":[516],"(D)":[517],"evaluation":[521,618],"CAR-T.":[524],"co-cultured":[527,624],"lymphoblastoid":[529],"line":[531,664],"(LCL)":[532],"indicated":[534,628],"E:T":[535,629],"ratio":[536,630],"supernatant":[538,632],"subjected":[540,634],"IFN-gamma":[542,636],"LDH-based":[545,639],"assay":[547,641],"(performed":[548,642],"after":[549,643],"16":[550,644],"h":[551,645],"co-":[553],"culture).":[554],"(E)":[555],"Mouse":[556],"survival":[557,602],"curve.":[558],"Jurkat":[559],"(Jurkat-Luc/ZT009)":[565],"inoculated":[567],"into":[568],"tail":[570],"vein":[571],"NSG":[573],"five":[576],"days":[577],"later":[578],"effector":[579],"injected":[582],"i.v.":[583],"Day":[585,676],"0.":[586],"dose":[588],"Of":[589],"set":[593],"three":[594,688],"doses,":[595],"5x106,":[596],"1x107":[597],"2x107":[599],"respectively.":[600],"monitored":[604],"until":[605],"moribund":[607],"all":[609],"control":[612],"group.":[613],"(F)":[614],"TCR-T.":[621],"C666.1":[626,662],"co-culture).":[647],"(G)":[648],"vivo":[650],"testing":[651],"B-":[656],"NDG":[657],"xenografted":[659],"HLA-matched":[661],"(5x106":[669],"cells/s.c.).":[670],"Tumor":[671],"volume":[672],"measured":[674],"till":[675],"30":[677],"inoculation.":[681],"(H)":[682],"pharmacokinetics":[684],"analyses":[685],"whole":[694],"blood":[695],"qPCR":[697],"primers":[699],"CAR/TCR":[703]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}